Table 2.

Association between adequate glycemic control—HbA1c < 7.0% (53 mmol/mol)—and gender, age and drug therapy (n = 3063)

Variable	HbA1c < 7.0% (53 mmol/mol) n (%)	OR (95% CI)1	p-value	ORaj (95% CI)2	p-value
Sex			0.27		-
Female	842 (45.6)	Reference		-
Male	531 (43.6)	0.92 (0.80–1.06)		-
Age			< 0.001		< 0.001
25–34 years old	14 (30.4)	Reference		Reference
35–44 years old	67 (35.4)	1.25 (0.63–2.52)		0.99 (0.46–2.15)
45–54 years old	175 (37.1)	1.35 (0.70–2.59)		1.16 (0.56–2.40)
55–64 years old	419 (45.1)	1.87 (0.99–3.56)		1.60 (0.78–3.26)
65–74 years old	416 (45.2)	1.88 (0.99–3.58)		1.79 (0.88–3.65)
≥ 75 years old	282 (55.8)	2.89 (1.51–5.55)		2.79 (1.35–5.76)
Drug therapy			< 0.001		< 0.001
Metformin only	599 (78.4)	Reference		Reference
Sulfonylurea only	281 (45.1)	0.23 (0.18–0.29)		0.21 (0.17–0.27)
Insulin only	114 (27.1)	0.10 (0.08–0.13)		0.09 (0.07–0.12)
Metformin + sulfonylureas	257 (38.2)	0.17 (0.13–0.21)		0.17 (0.13–0.21)
ADO3 + insulin	122 (20.9)	0.07 (0.06–0.09)		0.07 (0.05–0.09)
Total	1373 (44.8)	-

¹OR (95% CI): Odds Ratio and 95% confidence interval

²ORaj Odds Ratio adjusted for age and drug therapy and 95% confidence interval

³ADO oral antidiabetic